Pro Vise Management Group, LLC Eli Lilly & CO Transaction History

Pro Vise Management Group, LLC

$1.25 Billion
Q3 2024

A detailed history of Pro Vise Management Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Pro Vise Management Group, LLC holds 1,090 shares of LLY stock, worth $867,280. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,090

Previous 1,047 4.11%

Holding current value

$867,280

Previous $947,000 1.9%

% of portfolio

0.08%

Previous 0.08%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $33,202 - $41,280	43 Added 4.11%	1,090 $965,000
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $74,661 - $93,631	-103 Reduced 8.96%	1,047 $947,000
Q1 2024 May 09, 2024	SELL	$592.2 - $792.28 $200,163 - $267,790	-338 Reduced 22.72%	1,150 $894,000
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $36,763 - $43,339	70 Added 4.94%	1,488 $867,000
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $1.03 Million - $1.42 Million	-2,363 Reduced 62.5%	1,418 $761,000
Q2 2023 Aug 24, 2023	BUY	$350.74 - $468.98 $862,118 - $1.15 Million	2,458 Added 185.79%	3,781 $1.77 Million
Q1 2023 May 05, 2023	SELL	$310.63 - $364.82 $87,908 - $103,244	-283 Reduced 17.62%	1,323 $454,000
Q4 2022 Feb 09, 2023	BUY	$321.55 - $374.67 $283,285 - $330,084	881 Added 121.52%	1,606 $587,000
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $26,979 - $30,746	-91 Reduced 11.15%	725 $235,000
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $11,149 - $13,090	-40 Reduced 4.67%	816 $265,000
Q1 2022 Apr 27, 2022	BUY	$234.69 - $291.66 $18,305 - $22,749	78 Added 10.03%	856 $245,000
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $174,933 - $217,093	778 New	778 $215,000
Q3 2021 Oct 20, 2021	SELL	$221.6 - $272.71 $221,378 - $272,437	-999 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$180.55 - $233.54 $180,369 - $233,306	999 New	999 $229,000
Q4 2020 Jan 19, 2021	SELL	$130.46 - $172.63 $357,982 - $473,696	-2,744 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$146.22 - $169.13 $134,814 - $155,937	922 Added 50.6%	2,744 $406,000
Q2 2020 Aug 07, 2020	BUY	$136.42 - $164.18 $248,557 - $299,135	1,822 New	1,822 $299,000
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $452,141 - $532,203	-4,062 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $15,140 - $17,376	-200 Reduced 4.69%	4,062 $347,000
Q3 2017 Nov 08, 2017	BUY	$77.07 - $85.54 $328,472 - $364,571	4,262	4,262 $364,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Vise Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Vise Management Group, LLC with notifications on news.

Account

Pro Vise Management Group, LLC Eli Lilly & CO Transaction History